All Stories

  1. Polyherbal Formulation Attenuates Isoproterenol-Induced Cardiac Toxicity Through Regulation of Mitochondrial Bioenergetics, Lipid Toxicity, and Intrinsic Apoptotic Pathways in Rats
  2. Epithelial–mesenchymal transition and cancer-associated fibroblasts in tumor progression and therapy resistance: mechanistic convergence and therapeutic opportunities
  3. Toxicomicrobiomics: Unveiling the Role of Human Microbiome in Drug and Xenobiotic Metabolism
  4. Advancement in CAR T-Cell Therapy in Tumors
  5. Adverse Effects of CAR T-Cell Therapy and Management: Cytokine Release Syndrome and Neurotoxicity
  6. Clinical Success of CAR T Cells in Hematologic Cancers: Lessons from Leukemia and Lymphoma
  7. Combining CAR T Cells with Immunotherapies to Enhance Treatment Effectiveness
  8. Engineering CAR T Cells: Advances in Vector Design and Gene Editing
  9. From Bench to Bedside: Innovations and Challenges in CAR-T Cell Therapy Manufacturing and Regulation
  10. History and Evolution of CAR T-Cell Therapy
  11. Next-Generation CARs and Beyond: Synthetic Biology and Logic-Gates in Next-Generation CARs
  12. Optimizing CAR T-Cell Efficacy: Enhancing Proliferation, Persistence, and Memory
  13. Overcoming Challenges of CAR T-Cell Therapy in Solid Tumor Microenvironments
  14. Personalized CAR T-Cell Therapy: Tailoring to Patient-Specific Tumors
  15. Regulatory Landscape and Challenges in CAR-T Cell Therapy Development and Clinical Trials
  16. Biomarkers for targeted therapy and treatment decision making
  17. Cancer biomarker that are currently used in cancer therapy and under evaluation in clinical trials
  18. Biomarkers for cancer screening, diagnosis and targeted therapeutic approaches
  19. Classification of cancer biomarkers based on treatment strategies
  20. Future perspectives and challenges for identification and recognition of clinically significant cancer biomarkers
  21. Patient-centric approaches and personalized nanomedicine in skin cancer
  22. Emerging therapeutic approaches in neurobiology of type 2 diabetes
  23. Neural regulation of glucose homeostasis
  24. NANOG: A key element for reverse aging
  25. Reverse aging through immune driven signaling
  26. Combination of hydroxycitric acid and capsaicin regulates IRS-1/AMPK-mTOR-SREBP-1c Axis/NLRP3-NF-κB/Nrf-2-ARE signaling pathways to ameliorate the two-hit process in high-fat diet-induced hepatic steatosis
  27. Integrating CAR-T cells with other Immunotherapies for improved efficacy in cancer patients
  28. The Mediating Role of the Gut Microbiome in the Nutritional Prevention of Cancer
  29. Activated protein C promotes human lung cancer progression through the release of tumor extracellular vesicles and transfer of microRNA-200a
  30. Application and Prospects of Nanotechnology for Water Treatment
  31. Current Status and Future Prospects of Nanotechnology in the Healthcare Industry
  32. Regulatory dynamics of Th17 lymphocytes in oral squamous cell carcinoma: immune modulation and emerging immunotherapies
  33. Tumor microenvironment in breast cancer: cellular crosstalk, pathways, and therapeutic insights
  34. Molecular approaches of phytoremediation – a strategic regulator for pollution management
  35. Dissecting dietary hazards: cytogenotoxic impacts of monosodium glutamate, baking powder, and citric acid using Allium cepa assay
  36. Extracellular vesicles in acute myeloid leukemia: The role in disease pathogenesis, potential biomarker, and application in clinical settings
  37. Natural Products and their Bioactive Compounds for the Prevention and Treatment of Diabetes Mellitus: A Systematic Review
  38. Prevalence of Cancer in India with Respect to Leukaemia and their Factorial Relations
  39. Nanoplatforms for precision imaging and targeted therapy in oncology
  40. Beyond coagulation: Coagulation protease factor VIIa in cytoprotective response
  41. Frontiers in superbug management: innovating approaches to combat antimicrobial resistance
  42. Detection Methods in HPV-Related Cancers
  43. CAR T-Cell Therapies against Viral Oncogenesis
  44. Cytomegalovirus (CMV)
  45. Difficulties in Promptly Diagnosing and Treating Neonatal Herpes Simplex Virus Infection
  46. Global Epidemiology of Oncogenic Viral Infections
  47. Hepatitis B Virus Infection
  48. Host–Viral Interactions during Oncogenic Infections
  49. Human T-Cell Leukemia Virus (HTLV)-Induced Carcinogenesis and Its Molecular Detection
  50. Immune Response Associated with Oncogenic Viral Diseases
  51. Laboratory Animal Model for Oncogenic Virus
  52. Malignant Transformation In Vitro by Oncogenic Viruses
  53. Molecular Cancer Drug Discovery
  54. Types of Viral Oncogenic Viral Diseases
  55. Vaccines
  56. Viral Oncology
  57. Evaluation of Bloodstream Infections Associated with Carbapenem-Resistant Enterobacteriaceae in Paediatric and Adult Patients
  58. Epigenetic analysis in cancer research
  59. Gene therapies for neurodegenerative disease: current knowledge and challenges
  60. Gene therapy under clinical trials for neurodegenerative diseases
  61. Introduction to cancer biology and current research trends
  62. Transgene delivery system: viral, nonviral, and other methods for central nervous system
  63. Emerging biomarkers for non-invasive cancer diagnosis and treatment
  64. Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis
  65. Method Optimization and Validation of Antibiotics Residues in Milk Sample Using LC-MS/MS
  66. The role of extracellular vesicles in the pathogenesis of gynecological cancer
  67. MicroRNAs in extracellular vesicles: A potential role in cancer progression
  68. Development of New Screening Methods for SARS CoV 2 and its Associated Developing Variations
  69. Diagnosis and Treatment of Health Effects Caused by Airborne Contaminants
  70. Development of Personalized Medicine
  71. Nanobiotechnology in Personalized Oncology
  72. Phytoformulation with hydroxycitric acid and capsaicin protects against high-fat-diet-induced obesity cardiomyopathy by reducing cardiac lipid deposition and ameliorating inflammation and apoptosis in the heart
  73. Astroviruses: Overview and Emerging Disease
  74. Molecular Mechanisms of Human Papillomavirus-Induced Cervical Carcinogenesis
  75. Immunogenicity of cancer cells: An overview
  76. Risk Prediction and Diagnosis of Breast Cancer Using ML Algorithms
  77. CAR T-cell therapy: Reprogramming patient's immune cell to treat cancer
  78. An Updated Review on Influenza Viruses
  79. Avian Influenza: A Potential Threat to Human Health
  80. Crimean-Congo Haemorrhagic Fever Virus: A Complete Overview
  81. Novel Diagnostic Methods for Emerging Respiratory Viral Infection
  82. RAS: Circuitry and therapeutic targeting
  83. Effect of Allium Sativum on the Alcohol Induced Neuropathic Pain in Wistar Rats
  84. Cardiovascular Diseases and Nutraceuticals: Underlying Mechanism and Therapeutic Biomarkers
  85. Epigenetic Regulation of Breast Cancer
  86. Microbial indicators and methods for source tracking faecal contamination of groundwater
  87. Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope
  88. Expression profile of MUC1 protein in Pigeon allergens positive asthmatic
  89. Current updates on adaptive immune response by B cell and T cell stimulation and therapeutic strategies for novel coronavirus disease 2019 (COVID-19) treatment
  90. Phytopharmaceuticals in Cancer Treatment
  91. Epigenetic Regulation of Breast Cancer
  92. Research Article Non-synonymous de novo gene mutations in Wilms’ Tumor: Identification and characterization of new variants of WT1 and WT2 loci in Indian Population
  93. Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype
  94. Reversal of hypermethylation and reactivation of glutathione S-transferase pi 1 gene by curcumin in breast cancer cell line
  95. Breast cancer and human papillomavirus infection: No evidence of HPV etiology of breast cancer in Indian women